GANAB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.639400E-01
Normal-vs-Stage2
7.889000E-01
Normal-vs-Stage3
3.246600E-01
Normal-vs-Stage4
9.938600E-01
Stage1-vs-Stage2
8.180400E-01
Stage1-vs-Stage3
2.654000E-01
Stage1-vs-Stage4
5.337600E-01
Stage2-vs-Stage3
2.149400E-01
Stage2-vs-Stage4
7.650800E-01
Stage3-vs-Stage4
2.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.595000E-01
Normal-vs-AfricanAmerican
6.941600E-01
Normal-vs-Asian
5.050800E-01
Caucasian-vs-AfricanAmerican
3.425600E-01
Caucasian-vs-Asian
4.738000E-01
AfricanAmerican-vs-Asian
1.640600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.632600E-01
Normal-vs-Female
8.714200E-01
Male-vs-Female
3.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.726400E-01
Normal-vs-Age(41-60Yrs)
5.849000E-01
Normal-vs-Age(61-80Yrs)
4.212400E-01
Normal-vs-Age(81-100Yrs)
6.118200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.898000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.579000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.420800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.38880000000174E-06
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.413500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.617800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.376200E-01
Normal-vs-Daily Drinker
7.557600E-01
Normal-vs-Weekly Drinker
9.237400E-01
Normal-vs-Occasional Drinker
7.831200E-01
Normal-vs-Social Drinker
9.612600E-01
Non Drinker-vs-Daily Drinker
1.880810E-01
Non Drinker-vs-Weekly Drinker
3.234400E-01
Non Drinker-vs-Occasional Drinker
1.642210E-02
Non Drinker-vs-Social Drinker
8.713800E-02
Daily Drinker-vs-Weekly Drinker
8.191800E-01
Daily Drinker-vs-Occasional Drinker
2.593600E-01
Daily Drinker-vs-Social Drinker
6.237600E-01
Weekly Drinker-vs-Occasional Drinker
5.617000E-01
Weekly Drinker-vs-Social Drinker
8.953200E-01
Occasional Drinker-vs-Social Drinker
5.561200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.104600E-01
Normal-vs-Grade 2
8.350200E-01
Normal-vs-Grade 3
8.726400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.691600E-01
Grade 1-vs-Grade 3
1.080050E-01
Grade 1-vs-Grade 4
8.104600E-01
Grade 2-vs-Grade 3
1.907760E-01
Grade 2-vs-Grade 4
8.350200E-01
Grade 3-vs-Grade 4
8.726400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.784400E-01
Normal-vs-NonDiabetic
8.580600E-01
Diabetic-vs-NonDiabetic
5.988200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.936200E-01
Normal-vs-NoPancreatitis
6.660400E-01
Pancreatitis-vs-NoPancreatitis
4.902000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.287200E-01
Normal-vs-N1
7.775800E-01
N0-vs-N1
9.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.196000E-01
Normal-vs-TP53-NonMutant
5.997400E-01
TP53-Mutant-vs-TP53-NonMutant
8.555400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
